Literature DB >> 29201230

Inhibition of penile tunica albuginea myofibroblasts activity by adipose-derived stem cells.

Hesong Jiang1, Qingqiang Gao1, Xiaoyan Che1, Leilei Zhu1, Zheng Zhang1, Yun Chen1, Yutian Dai1.   

Abstract

The activation of tunica albuginea myofibroblasts (MFs) serves an essential role in Peyronie's disease (PD). Increasing evidence has reported that adipose tissue-derived stem cells (ADSCs) have been demonstrated to attenuate the symptoms of PD in animal models. However, the mechanisms of the antifibrotic effects of ADSCs in PD remain to be fully elucidated. In the present study, the inhibitory effects and possible mechanism of ADSCs on the activation of MFs derived from rat penile tunica albuginea were investigated. ADSCs were obtained from the paratesticular fat of Sprague Dawley rats. MFs were transformed from rat penile tunica albuginea fibroblasts through stimulation with 5 ng/ml tumor growth factor-β1. Transwell cell cultures were adopted for co-culture of ADSCs and MFs. Western blot analysis was used to assess changes in the expression levels of α smooth muscle actin (αSMA), collagen I, phosphorylated (p)-SMAD family member 2 (Smad2), Smad2, ras homolog family member A (RhoA), Rho associated coiled-coil containing protein kinase (ROCK)1 and ROCK2, caspase3, caspase9, and matrix metalloproteinases (MMPs). Collagen gel assays were used to assess cell contractility. Additionally, the concentration of hydroxyproline in the culture medium was detected using commercially available kits. It was demonstrated that ADSCs reduced the expression of αSMA and collagen I of MFs. Furthermore, p-Smad2, RhoA, ROCK1 and ROCK2 expression was significantly reduced in the MFs+ADSCs group compared with that in the MFs-only culture, while the expression of MMPs (MMP2, MMP3, MMP9 and MMP13) and caspases (caspase3 and caspase9) was upregulated. In addition, ADSCs were able to downregulate the concentration of hydroxyproline in the culture medium of MFs and reverse the contraction of MFs. Collectively, these results suggested that ADSCs inhibited the activation of MFs, decreased collagen production, and suppressed the contraction of myofibroblasts, via Smad and RhoA/ROCK signaling pathways. Furthermore, ADSCs reduced the deposition of collagen and promoted the apoptosis of MFs via MMPs, and caspases. Accordingly, the application of ADSCs may provide a novel therapeutic strategy for PD.

Entities:  

Keywords:  Peyronie's disease; adipose tissue-derived stem cells; fibrosis; myofibroblasts

Year:  2017        PMID: 29201230      PMCID: PMC5704342          DOI: 10.3892/etm.2017.5179

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  47 in total

Review 1.  Myofibroblasts. I. Paracrine cells important in health and disease.

Authors:  D W Powell; R C Mifflin; J D Valentich; S E Crowe; J I Saada; A B West
Journal:  Am J Physiol       Date:  1999-07

Review 2.  Matrix metalloproteinases and collagen catabolism.

Authors:  Janelle L Lauer-Fields; Darius Juska; Gregg B Fields
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

Review 3.  Physiological roles of Rho and Rho effectors in mammals.

Authors:  Dean Thumkeo; Sadanori Watanabe; Shuh Narumiya
Journal:  Eur J Cell Biol       Date:  2013-10-08       Impact factor: 4.492

4.  Effective delivery of stem cells using an extracellular matrix patch results in increased cell survival and proliferation and reduced scarring in skin wound healing.

Authors:  Mai T Lam; Allison Nauta; Nathaniel P Meyer; Joseph C Wu; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2012-11-16       Impact factor: 3.845

Review 5.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

6.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.

Authors:  Stefano Gatti; Stefania Bruno; Maria Chiara Deregibus; Andrea Sordi; Vincenzo Cantaluppi; Ciro Tetta; Giovanni Camussi
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

7.  Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis.

Authors:  Kathyrn D Rodgers; Velidi Rao; Daniel T Meehan; Nicole Fager; Philip Gotwals; Sarah T Ryan; Victor Koteliansky; Ryoichi Nemori; Dominic Cosgrove
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction.

Authors:  Lei-Lei Zhu; Zheng Zhang; He-Song Jiang; Hai Chen; Yun Chen; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285

9.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

10.  Intralesional injection of adipose-derived stem cells reduces hypertrophic scarring in a rabbit ear model.

Authors:  Qi Zhang; Li-Na Liu; Qi Yong; Jing-Cheng Deng; Wei-Gang Cao
Journal:  Stem Cell Res Ther       Date:  2015-08-18       Impact factor: 6.832

View more
  2 in total

1.  Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture.

Authors:  Maryam Masouminia; Robert Gelfand; Istvan Kovanecz; Dolores Vernet; James Tsao; Ruben Salas; Kenny Castro; Leila Loni; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2018-12       Impact factor: 3.802

Review 2.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.